{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:02:17Z","timestamp":1780354937243,"version":"3.54.1"},"reference-count":38,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PROM"],"DOI":"10.2147\/prom.s399658","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:05:11Z","timestamp":1684368311000},"page":"153-169","source":"Crossref","is-referenced-by-count":15,"title":["Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group"],"prefix":"10.1080","volume":"Volume 14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-4523","authenticated-orcid":true,"given":"Avery A","family":"Rizio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2450-7693","authenticated-orcid":true,"given":"Michelle K","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-658X","authenticated-orcid":true,"given":"Paula","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-4285","authenticated-orcid":true,"given":"Tiffany P","family":"Quock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Signorovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lousada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-2445","authenticated-orcid":true,"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1750-1172-7-54","volume":"7","author":"Desport","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.mayocp.2018.08.006","volume":"94","author":"Muchtar","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/ejh.13472","volume":"105","author":"Schulman","year":"2020","journal-title":"Eur J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41409-018-0284-4","volume":"54","author":"Varga","year":"2019","journal-title":"Bone Marrow Transpl"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000506498","volume":"143","author":"Sanchorawala","year":"2020","journal-title":"Acta Haematol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa2028631","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","volume":"32","author":"Lousada","year":"2015","journal-title":"Adv Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","volume":"11","author":"McCausland","year":"2018","journal-title":"Patient"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/13506129.2015.1102131","volume":"22","author":"Lin","year":"2015","journal-title":"Amyloid"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13023-016-0564-2","volume":"12","author":"Bayliss","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"ref15","unstructured":"Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Guidance for Industry. Food and Drug Administration (US); 2009."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13023-020-01525-2","volume":"15","author":"Inaugural Amyloidosis Forum","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1080\/03007995.2017.1297930","volume":"33","author":"Lin","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s11136-021-02943-w","volume":"32","author":"D\u2019Souza","year":"2022","journal-title":"Qual Life Res"},{"key":"ref19","unstructured":"Food and Drug Administration. Patient-Focused Drug Development: Methods to Identify What is Important to Patients. Guidance for Industry. Food and Drug Administration (US); 2022."},{"key":"ref20","unstructured":"Food and Drug Administration. Patient-Focused Drug Development: Collecting Comprehensive and Representative Input. Guidance for Industry. Food and Drug Administration (US); 2020."},{"key":"ref21","unstructured":"Food and Drug Administration. Patient-focused drug development: Selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for Industry [draft]. Food and Drug Administration (US): 2022."},{"key":"ref22","unstructured":"Lousada I. Considerations for Novel Endpoint Development in AL Amyloidosis. Presented at: Meeting of the Amyloidosis Forum; January 22, 2021. Available from: https:\/\/amyloidosisforum.org\/considerations-for-novel-endpoint-development-in-al-amyloidosis\/. Accessed January 22, 2021."},{"key":"ref23","first-page":"430","volume":"11","author":"Rizio","year":"2018","journal-title":"Am Health Drug Benefits"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.hoc.2020.08.003","volume":"34","author":"Lousada","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41687-017-0020-7","volume":"1","author":"White","year":"2017","journal-title":"J Patient Rep Outcomes"},{"key":"ref26","volume-title":"User\u2019s Manual for the SF-36v2 Health Survey","year":"2013"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/PROM.S146849","volume":"8","author":"White","year":"2017","journal-title":"Patient Relat Outcome Meas"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/bjh.15693","volume":"185","author":"McCausland","year":"2019","journal-title":"Br J Haematol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1182\/blood-2004-01-0089","volume":"104","author":"Seldin","year":"2004","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/bjh.14889","volume":"179","author":"Sanchorawala","year":"2017","journal-title":"Br J Haematol"},{"key":"ref31","first-page":"23","volume":"2","author":"D\u2019Souza","year":"2020","journal-title":"eClinicalMedicine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","volume":"27","author":"Hays","year":"2018","journal-title":"Qual Life Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41408-021-00412-8","volume":"11","author":"D\u2019Souza","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/13506129.2020.1713743","volume":"27","author":"D\u2019Souza","year":"2020","journal-title":"Amyloid"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/13506129.2016.1208081","volume":"23","author":"Shu","year":"2016","journal-title":"Amyloid"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e009038","DOI":"10.1161\/CIRCHEARTFAILURE.121.009038","volume":"15","author":"Maurer","year":"2022","journal-title":"Circ Heart Fail"},{"key":"ref37","unstructured":"Food and Drug Administration. Patient-focused drug development: Incorporating clinical outcome assessments into endpoints for regulatory decision-making. Guidance for Industry [draft]. Food and Drug Administration (US): 2023"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jval.2017.05.015","volume":"20","author":"Benjamin","year":"2017","journal-title":"Value Health"}],"container-title":["Patient Related Outcome Measures"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89806","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89806","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:25:16Z","timestamp":1780352716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/health-related-quality-of-life-instruments-for-clinical-trials-in-al-a-peer-reviewed-fulltext-article-PROM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":38,"URL":"https:\/\/doi.org\/10.2147\/prom.s399658","relation":{},"ISSN":["1179-271X"],"issn-type":[{"value":"1179-271X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}